Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 51.74
2.58 %
$ 9.58 B
Market Cap
-44.6
P/E
Price Target
Average
48.96%
Revenue Forecast
Estimate
17.30%
EBIT
Estimate
--84.84%
Net Income
Estimate
41.44%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Exact Sciences Corporation
Wall Street analysts predict an average 1-year price target for EXAS of $77.1 , with forecasts ranging from
a
low of
$65 to a high of $95 .
EXAS Lowest Price Target
Wall Street Target
65 USD
25.63%
EXAS Average Price Target
Wall Street Target
77.1 USD
48.96%
EXAS Highest Price Target
Wall Street Target
95 USD
83.61%
REVENUE FORECAST
Revenue Forecast Chart EXAS
EBIT FORECAST
EBIT Forecast Chart EXAS
NET INCOME FORECAST
Net Income Chart EXAS